Georg Karlaganis
- Oncology top 10%
- Surgery
- Molecular Biology
- Epidemiology
- Pharmacology top 5%
- Co-authors
- G. PaumgartnerJ BircherJan SjövallHans U. FischChristoph E. MinderR. SchwyzerB H LauterburgRené P. Schwarzenbach
- Topics
- Drug Transport and Resistance Mechanisms (18 papers)Analytical Chemistry and Chromatography (8 papers)Pediatric Hepatobiliary Diseases and Treatments (7 papers)
- Cited by
- PharmacologyHepatologyOncology
- Partner nations
- SwitzerlandSwedenUnited States
In The Last Decade
Georg Karlaganis
55 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 115
- Oncology 411
- Surgery 237
- Molecular Biology 189
- Epidemiology 179
- Pharmacology 157
Countries citing papers authored by Georg Karlaganis
This map shows the geographic impact of Georg Karlaganis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg Karlaganis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg Karlaganis more than expected).
Fields of papers citing papers by Georg Karlaganis
This network shows the impact of papers produced by Georg Karlaganis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg Karlaganis. The network helps show where Georg Karlaganis may publish in the future.
Co-authorship network of co-authors of Georg Karlaganis
This figure shows the co-authorship network connecting the top 25 collaborators of Georg Karlaganis. A scholar is included among the top collaborators of Georg Karlaganis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georg Karlaganis. Georg Karlaganis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 7 | |
| 3 | 43 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 35 | |
| 8 | 3 | |
| 9 | 18 | |
| 10 | 11 | |
| 11 | 31 | |
| 12 | 22 | |
| 13 | 14 | |
| 14 | 19 | |
| 15 | 21 | |
| 16 | 25 | |
| 17 | 66 | |
| 18 | 42 | |
| 19 | [Detection of 3 beta-hydroxy-5-cholenoic acid in human amniotic fluid]. | 1 |
| 20 | 18 |
About Georg Karlaganis
Georg Karlaganis is a scholar working on Pharmacology, Oncology and Clinical Biochemistry, having authored 56 papers that have together received 1.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (18 papers), Analytical Chemistry and Chromatography (8 papers) and Pediatric Hepatobiliary Diseases and Treatments (7 papers). The work is most often cited by research in Pharmacology (157 citations), Hepatology (125 citations) and Oncology (411 citations). Georg Karlaganis has collaborated with scholars based in Switzerland, Sweden and United States. Frequent co-authors include G. Paumgartner, J Bircher, Jan Sjövall, Hans U. Fisch, Christoph E. Minder, R. Schwyzer, B H Lauterburg, René P. Schwarzenbach, K. Y. Wong and A. L. Jones. Their work appears in journals such as Gastroenterology, Hepatology and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.